ES2088463T3 - Uso de enzimas. - Google Patents

Uso de enzimas.

Info

Publication number
ES2088463T3
ES2088463T3 ES91302396T ES91302396T ES2088463T3 ES 2088463 T3 ES2088463 T3 ES 2088463T3 ES 91302396 T ES91302396 T ES 91302396T ES 91302396 T ES91302396 T ES 91302396T ES 2088463 T3 ES2088463 T3 ES 2088463T3
Authority
ES
Spain
Prior art keywords
enzyme
link
enzymes
hypohalite
peroxidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91302396T
Other languages
English (en)
Inventor
Thomas Stewart Beggs
Paul James Davis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever NV
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909006329A external-priority patent/GB9006329D0/en
Priority claimed from GB909021671A external-priority patent/GB9021671D0/en
Application filed by Unilever NV filed Critical Unilever NV
Application granted granted Critical
Publication of ES2088463T3 publication Critical patent/ES2088463T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6815—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
    • A61K47/6885—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy the conjugate or the polymer being a starburst, a dendrimer, a cascade
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/94—Involves covalent bonding to the substrate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Detergent Compositions (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Cosmetics (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

UNO O MAS VEHICULOS, APTOS PARA ENTRAR POR LA BOCA, CONTIENEN POR LO MENOS DOS ENZIMAS QUE FUNCIONAN AL TIEMPO ADEMAS DE MEDIOS PARA UNIRLAS ENTRE SI. UNA ENZIMA GENERA UN INTERMEDIO QUE ES UTILIZADO POR LA OTRA ENZIMA PARA GENERAR UNA SUSTANCIA HIPOHILA PREFERIBLEMENTE, QUE ACTUA COMO EL LUGAR DEL BLANCO. LOS MEDIOS ENLAZADORES HACEN QUE EL INTERMEDIO SE CONVIERTA EN PEROXIDASA PARA LA ENZIMA QUE LO UTILIZA.
ES91302396T 1990-03-21 1991-03-20 Uso de enzimas. Expired - Lifetime ES2088463T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909006329A GB9006329D0 (en) 1990-03-21 1990-03-21 Cell killing
GB909021671A GB9021671D0 (en) 1990-10-05 1990-10-05 Delivery of agents

Publications (1)

Publication Number Publication Date
ES2088463T3 true ES2088463T3 (es) 1996-08-16

Family

ID=26296816

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91302396T Expired - Lifetime ES2088463T3 (es) 1990-03-21 1991-03-20 Uso de enzimas.

Country Status (8)

Country Link
EP (1) EP0451972B1 (es)
JP (1) JPH0584073A (es)
AT (1) ATE138579T1 (es)
AU (1) AU642980B2 (es)
CA (1) CA2038579C (es)
DE (1) DE69119817T2 (es)
ES (1) ES2088463T3 (es)
IN (1) IN172887B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07504571A (ja) * 1992-03-06 1995-05-25 クリージエン・インコーポレーテツド 病原体−標的生物触媒
NL9401048A (nl) * 1994-03-31 1995-11-01 Stichting Scheikundig Onderzoe Haloperoxidasen.
US5665333A (en) * 1995-01-17 1997-09-09 Homola; Andrew M. Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth
AU1194697A (en) * 1995-12-21 1997-07-17 Quest International B.V. Particle compositions
US5961958A (en) * 1996-07-16 1999-10-05 Four Star Partners Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth
US5972355A (en) * 1997-09-30 1999-10-26 E-L Management Corp. Stable compositions containing biologically active components
US5871714A (en) * 1997-10-16 1999-02-16 Pharmacal Biotechnologies, Inc. Compositions for controlling bacterial colonization
US7780882B2 (en) 1999-02-22 2010-08-24 Georgetown University Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent
CA2362550C (en) 1999-02-22 2010-05-11 Georgetown University Antibody fragment-targeted immunoliposomes for systemic gene delivery
US9034329B2 (en) 1999-02-22 2015-05-19 Georgetown University Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
ATE292475T1 (de) * 1999-09-16 2005-04-15 Unilever Nv Abgabesystem für ein mittel gegen schuppen
FR2803199B1 (fr) * 1999-12-29 2002-05-10 Jean Dominique Dana Procede de transformation des sucres alimentaires cariogenes en produits neutres acariogenes ou cariostatiques et composition pour la mise en oeuvre
DE60228842D1 (de) * 2001-04-02 2008-10-23 Univ Georgetown Vereinfachtes und verbessertes verfahren zur herstellung eines antikörper- oder antikörperfragment-targeted immunoliposoms oder polyplex für die systemische verabreichung eines therapeutischen oder diagnostischen mittels
AU2006303649B2 (en) * 2005-10-21 2013-02-28 Dupont Nutrition Biosciences Aps A composition comprising a coupled enzyme system
EP2023897A4 (en) 2006-05-15 2013-04-03 Univ Georgetown PREPARATION OF ANTIBODY OR ANTIBODY FRAGMENT-TUNED IMMUNOLIPOSOMES FOR SYSTEMIC ADMINISTRATION OF THERAPEUTIC OR DIAGNOSTIC ACTIVITIES AND USES THEREOF
WO2012087970A2 (en) 2010-12-20 2012-06-28 E. I. Du Pont De Nemours And Company Enzymatic peracid generation for use in oral care products

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578265A (en) * 1981-08-13 1986-03-25 Laclede Professional Products, Inc. Di-enzymatic dentifrice
ES2054678T5 (es) * 1986-08-18 1997-09-16 Dow Chemical Co Conjugados estrella.
WO1990003185A1 (en) * 1988-09-28 1990-04-05 Ideon Corporation Combination enzyme immunotherapeutics
AU5546090A (en) * 1989-06-30 1991-01-17 Brunswick Corporation Antibody-lactate oxidase conjugates
FR2651433B1 (fr) * 1989-09-07 1994-01-14 Dominique Dana Complexe enzymatique a activite sur le tartre et la carie dentaire.
AU642979B2 (en) * 1990-03-21 1993-11-04 Quest International B.V. Utilization and delivery of enzymes
AU5544090A (en) * 1990-04-26 1991-11-11 Ringdal Patenter A/S Activating unit for weapon

Also Published As

Publication number Publication date
EP0451972B1 (en) 1996-05-29
DE69119817T2 (de) 1996-10-31
ATE138579T1 (de) 1996-06-15
CA2038579C (en) 1998-06-23
AU642980B2 (en) 1993-11-04
DE69119817D1 (de) 1996-07-04
CA2038579A1 (en) 1991-09-22
IN172887B (es) 1993-12-25
JPH0584073A (ja) 1993-04-06
EP0451972A1 (en) 1991-10-16
AU7299791A (en) 1991-10-03

Similar Documents

Publication Publication Date Title
ES2088463T3 (es) Uso de enzimas.
ES2195970T3 (es) L-ribavirina y usos de la misma.
ES2155844T3 (es) Preparacion de n-alquilcarboxilatos de piperidinilo 3,4,4-trisustituidos e intermedios, utiles como antagonistas de opiaceos.
ES2164731T3 (es) Suspension acuosa tixotropica de agentes fitoprotectores.
ATE205533T1 (de) Derivate von alpha-hordothionin mit höherem behalt an lysin
DE3876050D1 (de) Okulare hypotensivagenzien.
ES2107447T3 (es) Ftalidas substituidas y ftalidas heterociclicas.
DK0934310T3 (da) Thiosyreafledte, monocykliske forbindelser som antikoaguleringsmidler
NO970221L (no) Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirus
ATE490311T1 (de) Mutanten der alpha-amylase
DK0638068T3 (da) Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
MY105128A (en) Bu-3608 derivatives.
MX9303913A (es) Composiciones detergentes liquidas acuosas concentradas que comprenden polivinilpirrolidona y un polimero de liberacion de suciedad basado en tereftalato.
ES540059A0 (es) Una composicion de conjugado de enzima estabilizado
ES2088464T3 (es) Uso y administracion de enzimas.
ATE55990T1 (de) Substituierte 4,6-alkoxypyridincarboxylatverbindungen.
CA2282726A1 (fr) Nouvelles utilisations de la sterilite male chez les plantes
TNSN89009A1 (fr) Utilisation d'inhibiteurs de l'enzyme de conversion de l'angiotensine
ES2075149T3 (es) Copolimeros de anhidrido maleico.
ES2115975T3 (es) Derivados de triariletileno utilizados terapeuticamente.
ES2051953T3 (es) Derivados isomeros de trimetilbiciclo(4,3,0)nonano.
ATE238791T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure als mukolytikum
ATE277614T1 (de) Anxiolytischer wirkstoff
DE3588208D1 (de) Cephalosporinderivative
ES2004489A4 (es) Gametocidas de piridina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 451972

Country of ref document: ES